ENSG00000182872 |
RBM10 |
lung adenocarcinoma |
missense_variant |
7.008% (182/2597) |
8 entries |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
sequence_alteration |
9.302% (48/516) |
3 entries |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
stop_gained |
9.302% (48/516) |
3 entries |
ENSG00000182872 |
RBM10 |
colorectal adenocarcinoma |
stop_gained |
4.88% (57/1168) |
2 entries |
ENSG00000182872 |
RBM10 |
colorectal adenocarcinoma |
frameshift_variant |
4.88% (57/1168) |
1 entry |
ENSG00000182872 |
RBM10 |
papillary thyroid carcinoma |
missense_variant |
5.285% (26/492) |
1 entry |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
conservative_inframe_deletion |
9.302% (48/516) |
1 entry |
ENSG00000182872 |
RBM10 |
lung adenocarcinoma |
stop_gained |
7.008% (182/2597) |
6 entries |
ENSG00000182872 |
RBM10 |
papillary thyroid carcinoma |
frameshift_variant |
5.285% (26/492) |
2 entries |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
frameshift_variant |
9.302% (48/516) |
2 entries |
ENSG00000182872 |
RBM10 |
papillary thyroid carcinoma |
stop_gained |
5.285% (26/492) |
2 entries |
ENSG00000182872 |
RBM10 |
lung adenocarcinoma |
frameshift_variant |
7.008% (182/2597) |
3 entries |
ENSG00000182872 |
RBM10 |
colorectal adenocarcinoma |
missense_variant |
4.88% (57/1168) |
2 entries |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
missense_variant |
9.302% (48/516) |
2 entries |
ENSG00000182872 |
RBM10 |
lung adenocarcinoma |
sequence_alteration |
7.008% (182/2597) |
5 entries |
ENSG00000182872 |
RBM10 |
colorectal adenocarcinoma |
sequence_alteration |
4.88% (57/1168) |
2 entries |
ENSG00000182872 |
RBM10 |
papillary thyroid carcinoma |
sequence_alteration |
5.285% (26/492) |
1 entry |
ENSG00000182872 |
RBM10 |
Ampulla of Vater Carcinoma |
stop_gained |
14.72% (29/197) |
1 entry |
ENSG00000182872 |
RBM10 |
kidney Wilms tumor |
frameshift_variant |
0.9375% (3/320) |
2 entries |
ENSG00000182872 |
RBM10 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
sequence_alteration |
3.409% (9/264) |
1 entry |
ENSG00000182872 |
RBM10 |
HER2 Positive Breast Carcinoma |
sequence_alteration |
5.063% (8/158) |
1 entry |
ENSG00000182872 |
RBM10 |
melanoma |
missense_variant |
6.897% (10/145) |
2 entries |
ENSG00000182872 |
RBM10 |
lobular breast carcinoma |
missense_variant |
2.553% (6/235) |
1 entry |
ENSG00000182872 |
RBM10 |
gastric adenocarcinoma |
missense_variant |
1.25% (9/720) |
1 entry |
ENSG00000182872 |
RBM10 |
chronic lymphocytic leukemia |
sequence_alteration |
0.6734% (6/891) |
1 entry |
ENSG00000182872 |
RBM10 |
non-small cell lung carcinoma |
sequence_alteration |
8.85% (10/113) |
1 entry |
ENSG00000182872 |
RBM10 |
non-small cell lung carcinoma |
missense_variant |
8.85% (10/113) |
2 entries |
ENSG00000182872 |
RBM10 |
Endometrial Endometrioid Adenocarcinoma |
sequence_alteration |
2.619% (17/649) |
1 entry |
ENSG00000182872 |
RBM10 |
clear cell renal carcinoma |
missense_variant |
0.2088% (3/1437) |
2 entries |
ENSG00000182872 |
RBM10 |
bile duct adenocarcinoma |
missense_variant |
0.7712% (3/389) |
2 entries |
ENSG00000182872 |
RBM10 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
frameshift_variant |
3.409% (9/264) |
2 entries |
ENSG00000182872 |
RBM10 |
thyroid carcinoma |
frameshift_variant |
1.728% (16/926) |
1 entry |
ENSG00000182872 |
RBM10 |
pancreatic ductal adenocarcinoma |
sequence_alteration |
2.496% (42/1683) |
1 entry |
ENSG00000182872 |
RBM10 |
prostate adenocarcinoma |
sequence_alteration |
0.5584% (12/2149) |
1 entry |
ENSG00000182872 |
RBM10 |
HER2 Positive Breast Carcinoma |
missense_variant |
5.063% (8/158) |
1 entry |
ENSG00000182872 |
RBM10 |
brain glioblastoma |
sequence_alteration |
0.2475% (3/1212) |
1 entry |
ENSG00000182872 |
RBM10 |
rectal adenocarcinoma |
stop_gained |
1.805% (10/554) |
2 entries |
ENSG00000182872 |
RBM10 |
breast ductal adenocarcinoma |
sequence_alteration |
2.452% (40/1631) |
1 entry |
ENSG00000182872 |
RBM10 |
skin melanoma |
stop_gained |
1.81% (21/1160) |
1 entry |
ENSG00000182872 |
RBM10 |
small cell lung carcinoma |
missense_variant |
2.237% (10/447) |
3 entries |
ENSG00000182872 |
RBM10 |
Ampulla of Vater Carcinoma |
sequence_alteration |
14.72% (29/197) |
1 entry |
ENSG00000182872 |
RBM10 |
hepatocellular carcinoma |
missense_variant |
0.203% (2/985) |
1 entry |
ENSG00000182872 |
RBM10 |
thyroid carcinoma |
missense_variant |
1.728% (16/926) |
1 entry |
ENSG00000182872 |
RBM10 |
squamous cell lung carcinoma |
frameshift_variant |
0.9045% (9/995) |
1 entry |
ENSG00000182872 |
RBM10 |
cecum adenocarcinoma |
missense_variant |
5.303% (14/264) |
2 entries |
ENSG00000182872 |
RBM10 |
anaplastic oligodendroglioma |
missense_variant |
3.529% (3/85) |
1 entry |
ENSG00000182872 |
RBM10 |
urothelial carcinoma |
missense_variant |
9.302% (8/86) |
1 entry |
ENSG00000182872 |
RBM10 |
breast ductal adenocarcinoma |
missense_variant |
2.452% (40/1631) |
2 entries |
ENSG00000182872 |
RBM10 |
esophageal adenocarcinoma |
missense_variant |
0.9141% (5/547) |
2 entries |
ENSG00000182872 |
RBM10 |
colon adenocarcinoma |
conservative_inframe_deletion |
3.147% (40/1271) |
1 entry |
ENSG00000182872 |
RBM10 |
colon adenocarcinoma |
missense_variant |
3.147% (40/1271) |
7 entries |
ENSG00000182872 |
RBM10 |
skin melanoma |
sequence_alteration |
1.81% (21/1160) |
3 entries |
ENSG00000182872 |
RBM10 |
cecum adenocarcinoma |
stop_gained |
5.303% (14/264) |
1 entry |
ENSG00000182872 |
RBM10 |
squamous cell lung carcinoma |
missense_variant |
0.9045% (9/995) |
1 entry |
ENSG00000182872 |
RBM10 |
pancreatic ductal adenocarcinoma |
stop_gained |
2.496% (42/1683) |
2 entries |
ENSG00000182872 |
RBM10 |
urothelial carcinoma |
stop_gained |
9.302% (8/86) |
1 entry |
ENSG00000182872 |
RBM10 |
renal cell carcinoma |
stop_gained |
4.478% (3/67) |
2 entries |
ENSG00000182872 |
RBM10 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
3.409% (9/264) |
2 entries |
ENSG00000182872 |
RBM10 |
bladder transitional cell carcinoma |
stop_lost |
9.302% (48/516) |
1 entry |
ENSG00000182872 |
RBM10 |
pancreatic ductal adenocarcinoma |
missense_variant |
2.496% (42/1683) |
2 entries |
ENSG00000182872 |
RBM10 |
rectal adenocarcinoma |
frameshift_variant |
1.805% (10/554) |
1 entry |
ENSG00000182872 |
RBM10 |
colon adenocarcinoma |
frameshift_variant |
3.147% (40/1271) |
2 entries |
ENSG00000182872 |
RBM10 |
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
2.619% (17/649) |
2 entries |
ENSG00000182872 |
RBM10 |
leiomyosarcoma |
missense_variant |
2.0% (2/100) |
1 entry |
ENSG00000182872 |
RBM10 |
lung adenocarcinoma |
conservative_inframe_deletion |
7.008% (182/2597) |
1 entry |
ENSG00000182872 |
RBM10 |
prostate adenocarcinoma |
missense_variant |
0.5584% (12/2149) |
2 entries |
ENSG00000182872 |
RBM10 |
bladder carcinoma |
stop_gained |
2.317% (13/561) |
1 entry |
ENSG00000182872 |
RBM10 |
colon adenocarcinoma |
stop_gained |
3.147% (40/1271) |
3 entries |
ENSG00000182872 |
RBM10 |
rectal adenocarcinoma |
missense_variant |
1.805% (10/554) |
2 entries |
ENSG00000182872 |
RBM10 |
cecum adenocarcinoma |
sequence_alteration |
5.303% (14/264) |
3 entries |
ENSG00000182872 |
RBM10 |
melanoma |
sequence_alteration |
6.897% (10/145) |
1 entry |
ENSG00000182872 |
RBM10 |
melanoma |
conservative_inframe_deletion |
6.897% (10/145) |
1 entry |
ENSG00000182872 |
RBM10 |
Merkel cell skin cancer |
sequence_alteration |
2.151% (2/93) |
1 entry |
ENSG00000182872 |
RBM10 |
female breast carcinoma |
missense_variant |
1.279% (5/391) |
2 entries |
ENSG00000182872 |
RBM10 |
gastric intestinal type adenocarcinoma |
sequence_alteration |
3.529% (3/85) |
2 entries |
ENSG00000182872 |
RBM10 |
squamous cell lung carcinoma |
sequence_alteration |
0.9045% (9/995) |
2 entries |
ENSG00000182872 |
RBM10 |
breast carcinoma |
sequence_alteration |
0.8632% (13/1506) |
2 entries |
ENSG00000182872 |
RBM10 |
colon adenocarcinoma |
sequence_alteration |
3.147% (40/1271) |
4 entries |
ENSG00000182872 |
RBM10 |
prostate carcinoma |
sequence_alteration |
1.653% (8/484) |
1 entry |
ENSG00000182872 |
RBM10 |
bladder carcinoma |
frameshift_variant |
2.317% (13/561) |
1 entry |
ENSG00000182872 |
RBM10 |
follicular thyroid carcinoma |
frameshift_variant |
5.97% (4/67) |
1 entry |
ENSG00000182872 |
RBM10 |
non-small cell lung carcinoma |
frameshift_variant |
8.85% (10/113) |
1 entry |
ENSG00000182872 |
RBM10 |
papillary thyroid carcinoma |
conservative_inframe_deletion |
5.285% (26/492) |
1 entry |
ENSG00000182872 |
RBM10 |
non-small cell lung carcinoma |
stop_gained |
8.85% (10/113) |
1 entry |
ENSG00000182872 |
RBM10 |
brain glioblastoma |
missense_variant |
0.2475% (3/1212) |
1 entry |
ENSG00000182872 |
RBM10 |
Gallbladder Adenocarcinoma |
stop_gained |
2.158% (3/139) |
2 entries |
ENSG00000182872 |
RBM10 |
ovarian serous adenocarcinoma |
missense_variant |
0.3601% (3/833) |
2 entries |
ENSG00000182872 |
RBM10 |
small cell lung carcinoma |
sequence_alteration |
2.237% (10/447) |
3 entries |
ENSG00000182872 |
RBM10 |
breast carcinoma |
missense_variant |
0.8632% (13/1506) |
2 entries |
ENSG00000182872 |
RBM10 |
skin melanoma |
missense_variant |
1.81% (21/1160) |
2 entries |
ENSG00000182872 |
RBM10 |
dedifferentiated liposarcoma |
missense_variant |
2.222% (1/45) |
1 entry |
ENSG00000182872 |
RBM10 |
Duodenal Adenocarcinoma |
frameshift_variant |
5.882% (1/17) |
1 entry |
ENSG00000182872 |
RBM10 |
rectal adenocarcinoma |
sequence_alteration |
1.805% (10/554) |
1 entry |
ENSG00000182872 |
RBM10 |
esophageal adenocarcinoma |
stop_gained |
0.9141% (5/547) |
1 entry |
ENSG00000182872 |
RBM10 |
anaplastic astrocytoma |
missense_variant |
0.7634% (1/131) |
1 entry |
ENSG00000182872 |
RBM10 |
kidney Wilms tumor |
sequence_alteration |
0.9375% (3/320) |
1 entry |
ENSG00000182872 |
RBM10 |
follicular thyroid carcinoma |
sequence_alteration |
5.97% (4/67) |
1 entry |
ENSG00000182872 |
RBM10 |
small intestinal neuroendocrine tumor G1 |
stop_gained |
1.695% (1/59) |
1 entry |
ENSG00000182872 |
RBM10 |
renal cell carcinoma |
sequence_alteration |
4.478% (3/67) |
1 entry |
ENSG00000182872 |
RBM10 |
hepatocellular carcinoma |
sequence_alteration |
0.203% (2/985) |
1 entry |
ENSG00000182872 |
RBM10 |
medullary thyroid gland carcinoma |
frameshift_variant |
2.857% (2/70) |
1 entry |
ENSG00000182872 |
RBM10 |
oral squamous cell carcinoma |
missense_variant |
0.7634% (2/262) |
1 entry |
ENSG00000182872 |
RBM10 |
esophageal adenocarcinoma |
sequence_alteration |
0.9141% (5/547) |
1 entry |
ENSG00000182872 |
RBM10 |
multiple myeloma |
sequence_alteration |
2.222% (1/45) |
1 entry |
ENSG00000182872 |
RBM10 |
oral squamous cell carcinoma |
stop_gained |
0.7634% (2/262) |
1 entry |
ENSG00000182872 |
RBM10 |
gastric intestinal type adenocarcinoma |
frameshift_variant |
3.529% (3/85) |
1 entry |
ENSG00000182872 |
RBM10 |
prostate carcinoma |
stop_gained |
1.653% (8/484) |
1 entry |
ENSG00000182872 |
RBM10 |
breast carcinoma |
conservative_inframe_deletion |
0.8632% (13/1506) |
1 entry |
ENSG00000182872 |
RBM10 |
breast ductal adenocarcinoma |
frameshift_variant |
2.452% (40/1631) |
1 entry |
ENSG00000182872 |
RBM10 |
urothelial carcinoma |
sequence_alteration |
9.302% (8/86) |
1 entry |
ENSG00000182872 |
RBM10 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
stop_gained |
3.409% (9/264) |
1 entry |
ENSG00000182872 |
RBM10 |
solitary fibrous tumor |
stop_gained |
3.448% (1/29) |
1 entry |
ENSG00000182872 |
RBM10 |
urothelial carcinoma |
frameshift_variant |
9.302% (8/86) |
1 entry |
ENSG00000182872 |
RBM10 |
Pleural Epithelioid Mesothelioma |
missense_variant |
0.7407% (1/135) |
1 entry |
ENSG00000182872 |
RBM10 |
chromophobe renal cell carcinoma |
stop_gained |
0.6803% (1/147) |
1 entry |
ENSG00000182872 |
RBM10 |
Tracheal Adenoid Cystic Carcinoma |
stop_gained |
25.0% (1/4) |
1 entry |
ENSG00000182872 |
RBM10 |
squamous cell lung carcinoma |
stop_gained |
0.9045% (9/995) |
1 entry |
ENSG00000182872 |
RBM10 |
urothelial carcinoma |
conservative_inframe_deletion |
9.302% (8/86) |
1 entry |
ENSG00000182872 |
RBM10 |
follicular thyroid carcinoma |
missense_variant |
5.97% (4/67) |
1 entry |
ENSG00000182872 |
RBM10 |
pancreatic neuroendocrine tumor |
stop_gained |
1.695% (4/236) |
1 entry |
ENSG00000182872 |
RBM10 |
esophageal squamous cell carcinoma |
missense_variant |
0.1462% (1/684) |
1 entry |
ENSG00000182872 |
RBM10 |
glioma |
missense_variant |
0.1669% (1/599) |
1 entry |
ENSG00000182872 |
RBM10 |
Bladder Squamous Cell Carcinoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000182872 |
RBM10 |
Endometrial Undifferentiated Carcinoma |
missense_variant |
33.33% (1/3) |
1 entry |
ENSG00000182872 |
RBM10 |
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000182872 |
RBM10 |
pseudomyxoma peritonei |
stop_gained |
10.0% (1/10) |
1 entry |
ENSG00000182872 |
RBM10 |
small cell lung carcinoma |
amino_acid_insertion |
2.237% (10/447) |
1 entry |
ENSG00000182872 |
RBM10 |
Uveal Melanoma |
missense_variant |
0.7812% (1/128) |
1 entry |
ENSG00000182872 |
RBM10 |
pancreatic ductal adenocarcinoma |
frameshift_variant |
2.496% (42/1683) |
1 entry |
ENSG00000182872 |
RBM10 |
kidney Wilms tumor |
stop_gained |
0.9375% (3/320) |
1 entry |
ENSG00000182872 |
RBM10 |
large cell lung carcinoma |
missense_variant |
5.263% (1/19) |
1 entry |
ENSG00000182872 |
RBM10 |
cecum adenocarcinoma |
conservative_inframe_deletion |
5.303% (14/264) |
1 entry |
ENSG00000182872 |
RBM10 |
Thymic Squamous Cell Carcinoma |
missense_variant |
25.0% (1/4) |
1 entry |
ENSG00000182872 |
RBM10 |
Brain Stem Glioblastoma |
sequence_alteration |
1.786% (1/56) |
1 entry |
ENSG00000182872 |
RBM10 |
esophageal adenocarcinoma |
frameshift_variant |
0.9141% (5/547) |
1 entry |
ENSG00000182872 |
RBM10 |
Gallbladder Adenocarcinoma |
missense_variant |
2.158% (3/139) |
1 entry |
ENSG00000182872 |
RBM10 |
central nervous system primitive neuroectodermal neoplasm |
frameshift_variant |
0.4464% (2/448) |
1 entry |
ENSG00000182872 |
RBM10 |
diffuse gastric adenocarcinoma |
sequence_alteration |
1.22% (1/82) |
1 entry |
ENSG00000182872 |
RBM10 |
ependymoma |
sequence_alteration |
1.852% (1/54) |
1 entry |
ENSG00000182872 |
RBM10 |
Uveal Melanoma |
sequence_alteration |
0.7812% (1/128) |
1 entry |
ENSG00000182872 |
RBM10 |
head and neck squamous cell carcinoma |
missense_variant |
0.159% (1/629) |
1 entry |
ENSG00000182872 |
RBM10 |
carcinoid tumor |
missense_variant |
25.0% (1/4) |
1 entry |
ENSG00000182872 |
RBM10 |
Spinal Cord Astrocytoma |
sequence_alteration |
25.0% (1/4) |
1 entry |
ENSG00000182872 |
RBM10 |
renal cell carcinoma |
missense_variant |
4.478% (3/67) |
1 entry |
ENSG00000182872 |
RBM10 |
Spinal Cord Astrocytoma |
missense_variant |
25.0% (1/4) |
1 entry |
ENSG00000182872 |
RBM10 |
thyroid carcinoma |
stop_gained |
1.728% (16/926) |
1 entry |
ENSG00000182872 |
RBM10 |
pharyngeal squamous cell carcinoma |
missense_variant |
1.235% (1/81) |
1 entry |
ENSG00000182872 |
RBM10 |
medullary thyroid gland carcinoma |
stop_gained |
2.857% (2/70) |
1 entry |
ENSG00000182872 |
RBM10 |
bronchoalveolar adenocarcinoma |
sequence_alteration |
4.545% (1/22) |
1 entry |
ENSG00000182872 |
RBM10 |
Cortisol-Producing Adrenal Cortex Adenoma |
missense_variant |
0.8065% (1/124) |
1 entry |
ENSG00000182872 |
RBM10 |
follicular thyroid carcinoma |
stop_gained |
5.97% (4/67) |
1 entry |
ENSG00000182872 |
RBM10 |
gastric intestinal type adenocarcinoma |
conservative_inframe_deletion |
3.529% (3/85) |
1 entry |
ENSG00000182872 |
RBM10 |
metaplastic breast carcinoma |
missense_variant |
1.667% (1/60) |
1 entry |
ENSG00000182872 |
RBM10 |
ovarian serous adenocarcinoma |
sequence_alteration |
0.3601% (3/833) |
1 entry |